Compare Stocks: DH, NRC, CTEV, and AMWL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMWL American Well	$13.22 +7.2%	$12.69	$3.71 ▼ $14.19	$218.77M	1.67	99,646 shs	119,114 shs
CTEV Claritev	$22.38 +1.9%	$31.41	$11.50 ▼ $73.68	$379.34M	0.93	162,497 shs	199,390 shs
DH Definitive Healthcare	$1.13 +2.7%	$0.91	$0.61 ▼ $3.04	$120.63M	1.4	450,647 shs	393,921 shs
NRC National Research	$20.69 +1.1%	$21.10	$11.32 ▼ $23.68	$470.70M	0.25	112,157 shs	74,695 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMWL American Well	+5.97%	-0.38%	-9.51%	-0.67%	+127.57%
CTEV Claritev	-1.00%	-10.53%	-29.62%	-24.46%	-60.48%
DH Definitive Healthcare	+10.00%	+12.67%	+14.58%	+51.70%	-61.67%
NRC National Research	+1.59%	+0.29%	-0.44%	-4.70%	+76.31%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMWL American Well	$13.22 +7.2%	$12.69	$3.71 ▼ $14.19	$218.77M	1.67	99,646 shs	119,114 shs
CTEV Claritev	$22.38 +1.9%	$31.41	$11.50 ▼ $73.68	$379.34M	0.93	162,497 shs	199,390 shs
DH Definitive Healthcare	$1.13 +2.7%	$0.91	$0.61 ▼ $3.04	$120.63M	1.4	450,647 shs	393,921 shs
NRC National Research	$20.69 +1.1%	$21.10	$11.32 ▼ $23.68	$470.70M	0.25	112,157 shs	74,695 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMWL American Well	+5.97%	-0.38%	-9.51%	-0.67%	+127.57%
CTEV Claritev	-1.00%	-10.53%	-29.62%	-24.46%	-60.48%
DH Definitive Healthcare	+10.00%	+12.67%	+14.58%	+51.70%	-61.67%
NRC National Research	+1.59%	+0.29%	-0.44%	-4.70%	+76.31%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMWL American Well	2.00	Hold	$9.50	-28.13% Downside
CTEV Claritev	2.56	Moderate Buy	$44.83	100.33% Upside
DH Definitive Healthcare	1.90	Reduce	$1.47	30.21% Upside
NRC National Research	2.00	Hold	$26.00	25.66% Upside

Current Analyst Ratings Breakdown

Latest DH, NRC, CTEV, and AMWL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/15/2026	AMWL American Well	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
10/9/2026	NRC National Research	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Hold (C-) ➝ Sell (D+)
10/5/2026	NRC National Research	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold
9/21/2026	CTEV Claritev	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
9/4/2026	DH Definitive Healthcare	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Neutral
8/31/2026	DH Definitive Healthcare	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
8/21/2026	NRC National Research	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (D+) ➝ Hold (C-)
8/20/2026	CTEV Claritev	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Overweight	$28.00 ➝ $40.00
8/13/2026	AMWL American Well	Truist Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target	Hold	$7.50 ➝ $12.00
8/13/2026	CTEV Claritev	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Strong Sell ➝ Hold
8/12/2026	CTEV Claritev	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Overweight	$73.00

(Data available from 10/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMWL American Well	$249.32M	0.88	N/A	N/A	$14.97 per share	0.88
CTEV Claritev	$965.41M	0.39	$15.65 per share	1.43	($10.10) per share	-2.22
DH Definitive Healthcare	$241.52M	0.50	$2.22 per share	0.51	$2.66 per share	0.42
NRC National Research	$137.39M	3.43	$1.29 per share	16.02	$0.62 per share	33.37

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMWL American Well	-$95.70M	-$4.77	N/A	N/A	N/A	-35.75%	-30.12%	-22.30%	11/3/2026 (Estimated)
CTEV Claritev	-$284.28M	-$17.01	N/A	N/A	N/A	-28.46%	N/A	-5.76%	N/A
DH Definitive Healthcare	-$138.93M	-$1.60	N/A	28.25	12.34	-72.28%	3.55%	1.63%	11/5/2026 (Estimated)
NRC National Research	$11.60M	$0.25	82.76	19.70	N/A	4.18%	164.26%	14.67%	10/26/2026 (Estimated)

Latest DH, NRC, CTEV, and AMWL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/5/2026	Q3 2026	DH Definitive Healthcare	$0.04	N/A	N/A	N/A	$54.57 million	N/A
11/3/2026	Q3 2026	AMWL American Well	-$0.66	N/A	N/A	N/A	$47.29 million	N/A
10/26/2026	Q3 2026	NRC National Research	$0.21	N/A	N/A	N/A	$35.80 million	N/A
8/10/2026	Q2 2026	DH Definitive Healthcare	$0.0427	$0.05	+$0.0073	-$0.05	$55.47 million	$55.20 million
8/7/2026	Q2 2026	CTEV Claritev	-$4.10	$1.41	+$5.51	-$3.49	N/A	$257.48 million
8/4/2026	Q2 2026	AMWL American Well	-$0.86	-$0.59	+$0.27	-$0.59	$49.87 million	$52.05 million
7/28/2026	Q2 2026	NRC National Research	-$0.15	$0.31	+$0.46	-$0.15	$34.90 million	$35.39 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMWL American Well	N/A	N/A	N/A	N/A	N/A
CTEV Claritev	N/A	N/A	N/A	N/A	N/A
DH Definitive Healthcare	N/A	N/A	N/A	N/A	N/A
NRC National Research	$0.64	3.09%	+19.88%	256.00%	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMWL American Well	N/A	2.90	2.89
CTEV Claritev	N/A	1.00	1.00
DH Definitive Healthcare	0.81	1.86	1.86
NRC National Research	13.13	0.65	0.65

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMWL American Well	56.05%
CTEV Claritev	87.15%
DH Definitive Healthcare	98.67%
NRC National Research	47.26%

Insider Ownership

Company	Insider Ownership
AMWL American Well	12.84%
CTEV Claritev	7.40%
DH Definitive Healthcare	17.09%
NRC National Research	9.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMWL American Well	562	16.55 million	14.43 million	Optionable
CTEV Claritev	3,000	16.95 million	15.69 million	Optionable
DH Definitive Healthcare	686	106.75 million	88.50 million	Optionable
NRC National Research	357	22.75 million	20.65 million	Optionable

DH, NRC, CTEV, and AMWL Headlines

Recent News About These Companies

National Research (NRC) Projected to Release Quarterly Earnings on Monday

October 19 at 2:27 AM | americanbankingnews.com

National Research (NRC) Set to Post Earnings on Monday

October 19 at 2:25 AM | marketbeat.com

New NRC Health Research Reveals What Sets High-Performing Health Systems Apart: Turning Patient Feedback Into Action

October 15, 2026 | businesswire.com

National Research (NASDAQ:NRC) Shares Cross Above Two Hundred Day Moving Average - Time to Sell?

October 15, 2026 | americanbankingnews.com

National Research (NASDAQ:NRC) Stock Price Crosses Above 200 Day Moving Average - Should You Sell?

October 15, 2026 | marketbeat.com

Over $135 million invested through NRC IRAP Defence Industry Assist to help Canadian businesses develop defence and dual-use technologies

October 15, 2026 | finance.yahoo.com

National Research (NASDAQ:NRC) Stock Moved Up to "Hold" by Zacks Research

October 7, 2026 | marketbeat.com

What is Citizens Jmp's Forecast for NRC Q3 Earnings?

October 6, 2026 | marketbeat.com

National Research (NASDAQ:NRC) Stock Price Crosses Above 200 Day Moving Average - Here's What Happened

October 1, 2026 | marketbeat.com

Former U.S. NRC Commissioner and U.S. DOE Nuclear Chief William D. Magwood, IV to Join newcleo's Board of Directors in January 2027

September 30, 2026 | globenewswire.com

NRC Health Trades at a Discount: Should You Buy, Sell or Hold?

September 28, 2026 | zacks.com

National Research Corporation (NASDAQ:NRC) to Issue Quarterly Dividend of $0.16

September 23, 2026 | marketbeat.com

New Momentum in the Nuclear Fuel Chain

September 14, 2026 | etftrends.comE

Mercy Earns National Honor for Excellence in Patient Experience

September 1, 2026 | prnewswire.com

Report Shows National Academies Spending Drop as Trump Threatens Funding

August 19, 2026 | aip.orgA

Record Backlog Powers NRC Health’s (NRC) Upward Potential

August 10, 2026 | insidermonkey.com

NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth

August 3, 2026 | zacks.com

National Research: Q2 Earnings Snapshot

July 30, 2026 | finance.yahoo.com

National Research (NASDAQ:NRC) Draws Fresh Market Focus

July 30, 2026 | kalkinemedia.comK

NRC Health (NRC) Q2 2026 Earnings Call Transcript

July 29, 2026 | seekingalpha.com

NRC Health Announces Second Quarter 2026 Results

July 28, 2026 | businesswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

DH, NRC, CTEV, and AMWL Company Descriptions

American Well NYSE:AMWL

$13.22 +0.89 (+7.21%)

Closing price 03:59 PM Eastern

Extended Trading

$13.24 +0.02 (+0.16%)

As of 06:34 PM Eastern

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Claritev NYSE:CTEV

$22.38 +0.42 (+1.91%)

As of 03:58 PM Eastern

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.

Definitive Healthcare NASDAQ:DH

$1.13 +0.03 (+2.73%)

Closing price 04:00 PM Eastern

Extended Trading

$1.14 +0.01 (+0.44%)

As of 05:44 PM Eastern

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

National Research NASDAQ:NRC

$20.69 +0.22 (+1.07%)

Closing price 04:00 PM Eastern

Extended Trading

$20.66 -0.03 (-0.12%)

As of 04:04 PM Eastern

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest DH, NRC, CTEV, and AMWL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest DH, NRC, CTEV, and AMWL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

DH, NRC, CTEV, and AMWL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

DH, NRC, CTEV, and AMWL Company Descriptions

American Well NYSE:AMWL

Claritev NYSE:CTEV

Definitive Healthcare NASDAQ:DH

National Research NASDAQ:NRC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest DH, NRC, CTEV, and AMWL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest DH, NRC, CTEV, and AMWL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

DH, NRC, CTEV, and AMWL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

DH, NRC, CTEV, and AMWL Company Descriptions

American Well NYSE:AMWL

Claritev NYSE:CTEV

Definitive Healthcare NASDAQ:DH

National Research NASDAQ:NRC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools